BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25845872)

  • 1. Impact of combination antimicrobial therapy on mortality risk for critically ill patients with carbapenem-resistant bacteremia.
    Bass SN; Bauer SR; Neuner EA; Lam SW
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3748-53. PubMed ID: 25845872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study.
    Lanini S; Costa AN; Puro V; Procaccio F; Grossi PA; Vespasiano F; Ricci A; Vesconi S; Ison MG; Carmeli Y; Ippolito G;
    PLoS One; 2015; 10(4):e0123706. PubMed ID: 25835018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli.
    Gibson GA; Bauer SR; Neuner EA; Bass SN; Lam SW
    Antimicrob Agents Chemother; 2016 Jan; 60(1):431-6. PubMed ID: 26525802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
    Shah PG; Shah SR
    J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
    Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
    Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric combination therapy for gram-negative bacteremia.
    Sick AC; Tschudin-Sutter S; Turnbull AE; Weissman SJ; Tamma PD
    Pediatrics; 2014 May; 133(5):e1148-55. PubMed ID: 24709936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an ESBL-endemic setting.
    Lew KY; Ng TM; Tan M; Tan SH; Lew EL; Ling LM; Ang B; Lye D; Teng CB
    J Antimicrob Chemother; 2015 Apr; 70(4):1219-25. PubMed ID: 25473028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experiences of bacteremia caused by metallo-beta-lactamase-producing gram-negative organisms.
    Lee NY; Yan JJ; Lee HC; Liu KH; Huang ST; Ko WC
    J Microbiol Immunol Infect; 2004 Dec; 37(6):343-9. PubMed ID: 15599466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification.
    Esterly JS; Wagner J; McLaughlin MM; Postelnick MJ; Qi C; Scheetz MH
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4885-90. PubMed ID: 22777044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic therapy for gram-negative bacteremia.
    Calandra T; Cometta A
    Infect Dis Clin North Am; 1991 Dec; 5(4):817-34. PubMed ID: 1783770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
    Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
    J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia.
    Tellor B; Skrupky LP; Symons W; High E; Micek ST; Mazuski JE
    Surg Infect (Larchmt); 2015 Dec; 16(6):785-93. PubMed ID: 26258265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
    Thatrimontrichai A; Apisarnthanarak A; Chanvitan P; Janjindamai W; Dissaneevate S; Maneenil G
    Pediatr Infect Dis J; 2013 Feb; 32(2):140-5. PubMed ID: 22935872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.
    Micek ST; Welch EC; Khan J; Pervez M; Doherty JA; Reichley RM; Hoppe-Bauer J; Dunne WM; Kollef MH
    J Hosp Med; 2011 Sep; 6(7):405-10. PubMed ID: 21916003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.
    Borer A; Saidel-Odes L; Riesenberg K; Eskira S; Peled N; Nativ R; Schlaeffer F; Sherf M
    Infect Control Hosp Epidemiol; 2009 Oct; 30(10):972-6. PubMed ID: 19712030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
    Munoz-Price LS; Zembower T; Penugonda S; Schreckenberger P; Lavin MA; Welbel S; Vais D; Baig M; Mohapatra S; Quinn JP; Weinstein RA
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1057-62. PubMed ID: 20715975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.